Impact of Continuing Medical Education (CME) Insulin Program

Completed

• Conditions: Diabetes

• Registration Number: NCT00824603
• Lead Sponsor: HealthPartners Institute

Brief Summary

The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.

Detailed Description

We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. Specifically, we will address the following questions:

Question 1. Clinical guidelines. Is insulin initiated earlier (at a lower A1C)?

Question 2. Decision-making. Does confidence in selecting a starting insulin regimen change? Does confidence in selecting a starting insulin dose change? Does confidence in adjusting insulin change? Does confidence in discussion nutrition guidelines change?

Question 3. Application. Do more patients start using insulin? Who usually selects starting dose? How is starting dose selected? How often is insulin adjusted?

Question 4. Resources. How available are protocols for insulin use? How available is adequate time to monitor insulin therapy? How available is staff to teach insulin injections? How available is staff to help adjust insulin?

Study Timeline

• Study Start: 2006-06
• Study First Submitted: 2009-01-15
• Study First Submitted QC: 2009-01-16
• Study First Posted: 2009-01-19
• Primary Completion: 2009-08
• Study Completion: 2009-08
• Status Verified: 2013-08
• Last Update Submitted: 2015-11-30
• Last Update Posted: 2015-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 294

Inclusion Criteria

• primary care provider attending CME training

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program.	pre program survey & 2-4 month post program survey

Secondary Outcome Measures

Name	Time	Method
pre-CME training level of patient's A1c when starting insulin therapy compared to post-CME training level of patient's A1c when starting insulin therapy	pre program survey and 2-4 month post program survey

Trial Locations

Locations (1)

International Diabetes Center; 🇺🇸 Minneapolis, Minnesota, United States